SUN Zixu, DONG Xia, ZHAO Baomin, JIA Haili, MA Xiaorui, GU Wei. Effect and mechanism of salidroside for 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine induced Parkinson's disease in mice[J]. Journal of Clinical Medicine in Practice, 2023, 27(22): 55-61, 66. DOI: 10.7619/jcmp.20232362
Citation: SUN Zixu, DONG Xia, ZHAO Baomin, JIA Haili, MA Xiaorui, GU Wei. Effect and mechanism of salidroside for 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine induced Parkinson's disease in mice[J]. Journal of Clinical Medicine in Practice, 2023, 27(22): 55-61, 66. DOI: 10.7619/jcmp.20232362

Effect and mechanism of salidroside for 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine induced Parkinson's disease in mice

More Information
  • Received Date: July 25, 2023
  • Revised Date: September 11, 2023
  • Available Online: December 05, 2023
  • Objective 

    To investigate the effect and mechanism of salidroside on1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced Parkinson's disease (PD) in mice.

    Methods 

    C57BL/6J mice were induced by MPTP to establish a PD mouse model and the movement track of mice was recorded by open field experiment. The expression of tyrosine hydroxylase (TH), α-synuclein (α-syn), nuclear factor E2 associated factor 2 (Nrf2) and quinone oxidoreductase 1 (NQO1) were detected by immunohistochemistry in brain tissue of mice. SN4741 cells were stimulated by MPTP to establish a PD cell model in vitro. MPTP stimulation of SN4741 cells to establish an in vitro cell model of PD. After pretreatment with salidroside, TUNEL was used to detect cell apoptosis in each group. The expressions of TH, α-syn, Nrf2 and NQO1 were detected by immunofluorescence. Nrf2 expression was knocked down by being transfected with si-RNA, and apoptosis condition was detected by TUNEL assay. The expression levels of interleukin-1β (IL-1β) and interleukin-18 (IL-18) protein in brain tissue extract and cell culture were detected by enzyme-linked immunosorbent assay (ELISA).

    Results 

    The open field experiment results showed that salidroside could improve 3 min total distance of activity, average speed and activity track of PD mice (P < 0.05). Compared with the PD model mice, the salidroside treated mice showed significantly increased expression of TH, Nrf2 and NQO1 in the brain, and reduced expression of IL-18, α-Syn, IL-1β. Compared with the MPTP stimulated cells, the salidroside pretreatment group showed a decrease in cell apoptosis and an increase in the expressions of TH, Nrf2 and NQO1, but reduced expressions in α-Syn, IL-1β and IL-18. After si-RNA knockdown of Nrf2 expression, the protective effect of salidroside on MPTP stimulated cells weakened or even disappeared.

    Conclusion 

    Salidroside may alleviate neuronal apoptosis by activating Nrf2-ARE signaling pathway, which is expected to be a new drug for PD treatment.

  • [1]
    COSTA H N, ESTEVES A R, EMPADINHAS N, et al. Parkinson's disease: a multisystem disorder[J]. Neurosci Bull, 2023, 39(1): 113-124. doi: 10.1007/s12264-022-00934-6
    [2]
    李亚楠. 自拟补益肝肾汤与左旋多巴联用对帕金森病患者焦虑评分、睡眠评分的影响[J]. 实用临床医药杂志, 2020, 24(11): 44-47. doi: 10.7619/jcmp.202011012
    [3]
    PAN L N, LI C R, MENG L X, et al. Tau accelerates α-synuclein aggregation and spreading in Parkinson's disease[J]. Brain, 2022, 145(10): 3454-3471. doi: 10.1093/brain/awac171
    [4]
    ANANDHAN A, CHEN C, NGUYEN N, et al. α-Syn overexpression, NRF2 suppression, and enhanced ferroptosis create a vicious cycle of neuronal loss in Parkinson's disease[J]. Free Radic Biol Med, 2022, 192: 130-140.
    [5]
    LIU S N, PI J B, ZHANG Q. Signal amplification in the KEAP1-NRF2-ARE antioxidant response pathway[J]. Redox Biol, 2022, 54: 102389. doi: 10.1016/j.redox.2022.102389
    [6]
    YAO Y Y, REN Z C, YANG R H, et al. Salidroside reduces neuropathology in Alzheimer's disease models by targeting NRF2/SIRT3 pathway[J]. Cell Biosci, 2022, 12(1): 180. doi: 10.1186/s13578-022-00918-z
    [7]
    LIU X M, ZHOU M X, DAI Z Z, et al. Salidroside alleviates ulcerative colitis via inhibiting macrophage pyroptosis and repairing the dysbacteriosis-associated Th17/Treg imbalance[J]. Phytother Res, 2023, 37(2): 367-382. doi: 10.1002/ptr.7636
    [8]
    KORBOZOVA N K, KUDRINA N O, ZHUKOVA N A, et al. Antihypothyroid effect of salidroside[J]. Molecules, 2022, 27(21): 7487. doi: 10.3390/molecules27217487
    [9]
    ABUSRAIR A H, ELSEKAILY W, BOHLEGA S. Tremor in Parkinson's disease: from pathophysiology to advanced therapies[J]. Tremor Other Hyperkinet Mov, 2022, 12: 29. doi: 10.5334/tohm.712
    [10]
    CORTES-ALTAMIRANO J L, REYES-LONG S, BANDALA C, et al. Neuropathic pain in Parkinson's disease[J]. Neurol India, 2022, 70(5): 1879-1886. doi: 10.4103/0028-3886.359257
    [11]
    WU L K, AGARWAL S, KUO C H, et al. Artemisia Leaf Extract protects against neuron toxicity by TRPML1 activation and promoting autophagy/mitophagy clearance in both in vitro and in vivo models of MPP+/MPTP-induced Parkinson's disease[J]. Phytomedicine, 2022, 104: 154250. doi: 10.1016/j.phymed.2022.154250
    [12]
    LI L, YAO W L. The therapeutic potential of salidroside for Parkinson's disease[J]. Planta Med, 2023, 89(4): 353-363. doi: 10.1055/a-1948-3179
    [13]
    KAM T I, PARK H, CHOU S C, et al. Amelioration of pathologic α-synuclein-induced Parkinson's disease by irisin[J]. Proc Natl Acad Sci U S A, 2022, 119(36): e2204835119. doi: 10.1073/pnas.2204835119
    [14]
    GEORGE M, THARAKAN M, CULBERSON J, et al. Role of Nrf2 in aging, Alzheimer's and other neurodegenerative diseases[J]. Ageing Res Rev, 2022, 82: 101756. doi: 10.1016/j.arr.2022.101756
    [15]
    RAJAN S, TRYPHENA K P, KHAN S, et al. Understanding the involvement of innate immunity and the Nrf2-NLRP3 axis on mitochondrial health in Parkinson's disease[J]. Ageing Res Rev, 2023, 87: 101915. doi: 10.1016/j.arr.2023.101915
    [16]
    WANG Q H, BOTCHWAY B O A, ZHANG Y, et al. Ellagic acid activates the Keap1-Nrf2-ARE signaling pathway in improving Parkinson's disease: a review[J]. Biomedecine Pharmacother, 2022, 156: 113848. doi: 10.1016/j.biopha.2022.113848
  • Related Articles

    [1]ZHOU Zeng, XU Jing, FENG Zhaohai, ZHENG Yingwei, CUI Min, WANG Zongyu, FANG Fang, LI Meiying. Diagnostic value of electromyographic tremor indicators for Parkinson's disease based on Logistic regression model[J]. Journal of Clinical Medicine in Practice, 2025, 29(1): 33-38. DOI: 10.7619/jcmp.20241497
    [2]CHEN Xiaohui, JIAO Zishan, WANG Nana, SHA Kaihui. Decision tree C5.0 versus Logistic regression model in predicting postpartum diastasis recti abdominis[J]. Journal of Clinical Medicine in Practice, 2023, 27(16): 115-120, 126. DOI: 10.7619/jcmp.20230893
    [3]YANG Yang, ZHU Yi, SUN Hao. Analysis of risk factors of nine deaths cansed by tetanus[J]. Journal of Clinical Medicine in Practice, 2020, 24(22): 63-65,69. DOI: 10.7619/jcmp.202022018
    [4]FENG Xuewu, SHI Leijun. Analysis on risk factors of femoral head necrosis after operation in patients with traumatic femoral neck fractures[J]. Journal of Clinical Medicine in Practice, 2020, 24(13): 68-70,74. DOI: 10.7619/jcmp.202013020
    [5]ZHOU Zongbin, ZHAO Guifen, LAN Wenquan, LI Yuanfa, ZHOU Zhigang. Analysis of influencing factors of cancer-related anemia in digestive tract tumor patients[J]. Journal of Clinical Medicine in Practice, 2020, 24(8): 63-65. DOI: 10.7619/jcmp.202008016
    [6]ZHOU Hong, XU Chao, YE Shuping. Analysis of Logistic risk factors in the prognosis of subarachnoid hemorrhage[J]. Journal of Clinical Medicine in Practice, 2017, (19): 41-43. DOI: 10.7619/jcmp.201719012
    [7]LI Yunduan, LIU Weiwu, XU Xiuying. Multivariate analysis of fetal growth restriction and its prevention measures[J]. Journal of Clinical Medicine in Practice, 2017, (1): 90-93. DOI: 10.7619/jcmp.201701027
    [8]LIU Ying. Multivariate Logistic regression analysis in infection of operation area after operation for open fracture of tibia and fibula[J]. Journal of Clinical Medicine in Practice, 2017, (1): 75-77. DOI: 10.7619/jcmp.201701022
    [9]MENG Mei, LI Ping, ZHAO Xiaolan. Related factors leading to limb pain after PICC for 24 h by Logistic regression analysis and its nursing countermeasures[J]. Journal of Clinical Medicine in Practice, 2016, (14): 49-51. DOI: 10.7619/jcmp.201614016
    [10]HUA li-ming, YANG He-ping, LU Xin-hua, ZHOU Shao-pin. LOGISTIC REGRESSION ANALYSIS ON THE RISK FACTORS FOR NON-DIABETIC CEREBRAL INFARCTION PATIENTS[J]. Journal of Clinical Medicine in Practice, 2005, (3): 67-70. DOI: 10.3969/j.issn.1672-2353.2005.03.023
  • Cited by

    Periodical cited type(8)

    1. 秦琪,宋易坤,李彤. 宫颈癌腹腔镜根治术的疗效及手术部位感染的影响因素分析. 实用癌症杂志. 2024(05): 845-848 .
    2. 王红利,王导利,林换弟. 经脐单孔腹腔镜盆腔淋巴结切除联合经阴道广泛子宫切除术治疗早期宫颈癌的临床疗效评价. 临床和实验医学杂志. 2024(07): 741-745 .
    3. 曾海荣,黄丹,张建军,华海琴. 外周血CD4~+CD25~+、CD8~+CD28~+调节性T细胞水平对早期宫颈癌患者腹腔镜根治术后预后的预测价值. 中国临床新医学. 2024(07): 800-805 .
    4. 李晓娟,陈宣彤. 健康行为改变理论对宫颈癌术后盆底肌功能及膀胱功能康复护理的影响. 实用妇科内分泌电子杂志. 2023(31): 144-146 .
    5. 赵阳,张晓莲,王丹丹. 多孔腹腔镜根治术治疗宫颈癌的疗效及对患者负性情绪和预后的影响. 癌症进展. 2022(21): 2237-2240 .
    6. 赵博,徐斌,王姣. 高危型人乳头瘤病毒检测对不同年龄段宫颈癌筛查临床研究. 临床军医杂志. 2021(07): 744-746 .
    7. 李明明. 腹腔镜与开腹宫颈癌根治术治疗早期宫颈癌患者的效果比较. 中国民康医学. 2020(24): 130-132 .
    8. 冯艳华. 经腹腔镜与开腹手术治疗早期宫颈癌的临床疗效及价值比较. 实用妇科内分泌电子杂志. 2020(07): 40+43 .

    Other cited types(1)

Catalog

    Article views (168) PDF downloads (10) Cited by(9)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return